The NB Protein of Influenza B Virus Is Not Necessary for Virus Replication In Vitro
Open Access
- 15 May 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (10), 6050-6054
- https://doi.org/10.1128/jvi.77.10.6050-6054.2003
Abstract
The NB protein of influenza B virus is thought to function as an ion channel and therefore would be expected to have an essential function in viral replication. Because direct evidence for its absolute requirement in the viral life cycle is lacking, we generated NB knockout viruses by reverse genetics and tested their growth properties both in vitro and in vivo. Mutants not expressing NB replicated as efficiently as the wild-type virus in cell culture, whereas in mice they showed restricted growth compared with findings for the wild-type virus. Thus, the NB protein is not essential for influenza B virus replication in cell culture but promotes efficient growth in mice.Keywords
This publication has 38 references indexed in Scilit:
- Influenza A Virus Can Undergo Multiple Cycles of Replication without M2 Ion Channel ActivityJournal of Virology, 2001
- Transmembrane Peptide NB of Influenza B: A Simulation, Structure, and Conductance StudyBiochemistry, 2000
- Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV‐1‐infected cellsFEBS Letters, 1996
- The NB protein is an integral component of the membrane of influenza B virusJournal of General Virology, 1996
- The HA1 of cold-adapted influenza B vaccine is not altered during replication in human vaccineesVirus Research, 1995
- Influenza virus M2 protein has ion channel activityCell, 1992
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Comparison of Live Attenuated Cold-Adapted and Avian-Human Influenza A/Bethesda/85 (H3N2) Reassortant Virus Vaccines in Infants and ChildrenThe Journal of Infectious Diseases, 1990
- Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trialVaccine, 1986
- Cold-Adapted Recombinant Influenza A Virus Vaccines in Seronegative Young ChildrenThe Journal of Infectious Diseases, 1982